主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
SNDX
#1700
Syndax Pharmaceuticals, Inc.
21.7
1
+6.89%
版块:
基础:
利润货币:
日范围
年范围
日变化
+6.89%
每月变动
+1.92%
6个月变化
+32.54%
年变化
+43.02%
前一天收盘价
20.3
1
Open
21.7
1
Bid
Ask
Low
21.7
1
High
21.7
1
交易量
124
市场
股票
医疗保健
SNDX
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
新闻
Stifel上调Syndax Pharmaceuticals目标价,看好药品销售前景
Stifel raises Syndax Pharmaceuticals stock price target on drug sales
Syndax Pharmaceuticals, Inc. (SNDX) Q4 2025 Earnings Call Transcript
Syndax 2025年第四季度业绩:收入激增50%,盈利路径明确
Syndax Q4 2025 slides: revenue surges 50%, profitability path outlined
Syndax Pharmaceuticals (SNDX) Reports Q4 Loss, Tops Revenue Estimates
Syndax Pharmaceuticals Q4 每股收益 逊于预期, 营收 超出预期
Syndax Pharmaceuticals earnings missed by $0.19, revenue topped estimates
Syndax面临财报考验,抗癌药物上市提速
Syndax faces earnings test as cancer drug launches accelerate
新达制药参加古根海姆峰会:强劲增长与战略扩张
Syndax Pharmaceuticals' Early Launch Success Signals Continued Growth Into 2026 (NASDAQ:SNDX)